panCELLa

At Pluristyx, we are dedicated to assisting our clients in the development of revolutionary cellular therapeutics. At Pluristyx, we provide end-to-end support for early product development. About us we are committed to lowering the barrier to entry, providing a swift translation to clinic, and ensure the best path to commercialization for the next generation of iPSC-derived treatments. Pluristyx develops innovative solutions that empower breakthroughs in stem cell therapies, offering the potential to effectively treat diseases. Our service offering, the panCELLa Platform, represents a remarkable step in stem cell research, offering enhanced freedom to operate and unparalleled product development at a significantly accelerated timeline. We manufacture our cells to the highest industry standards and are dedicated to maximizing the impact on patients’ lives. Pluristyx is armed with exclusive, worldwide licenses to cutting-edge techniques and technologies that set us apart in the industry. We are motivated by a vision to transform concepts into concrete outcomes and strive to achieve transformative results that will have a positive societal impact.